the guy/girl didn’t even know the parameters of our phase 3 trial this morning, but in minutes has been able to conclude that our treatment will fail to treat CLBP.
you’d think that given all the unknowns with CLBP, there might be room for new clinical data to change some minds or warrant an open mind.
so I find it very suspicious when someone claims to know this won’t work without demonstrating any understanding of the mechanism of action of these cells or the trial data generated, be it pre-clinical or phase 2.
MSB Trading 2020 - a new dawn, page-12012
-
- There are more pages in this discussion • 1,059 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |